🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Hexal AG — Licensed Medicines

18 medicines held by Hexal AG on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 18 products held by Hexal AG
MedicineActive substanceLicence holderStatus
Epoetin alfa HEXAL 1 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/411/1-2
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 10 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/411/15-16
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 2 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/411/3-4
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 20 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/411/21-22
Epoetin alfa Hexal AG
Epoetin alfa HEXAL 3 000 IU/0.3 mL solution for injection in a pre-filled syringe
EU/1/07/411/5-6
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 30 000 IU/0.75 mL solution for injection in a pre-filled syringe
EU/1/07/411/23-24
Epoetin alfa Hexal AG
Epoetin alfa HEXAL 4 000 IU/0.4 mL solution for injection in a pre-filled syringe
EU/1/07/411/7-8
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 40 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/411/25-26
Epoetin alfa Hexal AG
Epoetin alfa HEXAL 5 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/411/9-10
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 6 000 IU/0.6 mL solution for injection in a pre-filled syringe
EU/1/07/411/11-12
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 8 000 IU/0.8 mL solution for injection in a pre-filled syringe
EU/1/07/411/13-14
Recombinant human erythropoietin alfa Hexal AG
Filgrastim Hexal 30 MU (60 MU/ml) Solution for injection or infusion
EU/1/08/496/1-4
Ep2006 (recombinant human granulocyte-colony stimulating factor) Hexal AG
Filgrastim Hexal 48 MU (96 MU/ml) Solution for injection or infusion
EU/1/08/496/5-8
Ep2006 (recombinant human granulocyte-colony stimulating factor) Hexal AG
Rivastigmine HEXAL 1.5 mg hard capsules
EU/1/09/589/1-4
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 2 mg/ml oral solution
EU/1/09/589/017-018
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 3 mg hard capsules
EU/1/09/589/5-8
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 4.5 mg hard capsules
EU/1/09/589/9-12
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 6 mg hard capsules
EU/1/09/589/13-16
Rivastigmine hydrogen tartrate Hexal AG

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.